This is a medicine used to end a pregnancy. It works by blocking a hormone called progesterone. This helps to stop the pregnancy from developing and can cause bleeding.
Every report comes from a Lived member, sent anonymously.
Have you tried Mifepristone for Miscarriage?
Mifepristone is a prescription medicine that blocks the hormone progesterone and, at higher doses, the stress hormone cortisol. In the US it comes as two very different products, with different doses, risks and rules, so facts about one do not carry over to the other. The first is a single 200 mg tablet, sold as Mifeprex and as a generic, and sometimes called the abortion pill or by its early research name, RU-486. Taken with a second medicine, misoprostol, it is approved to end a pregnancy in the uterus up to 70 days (10 weeks) after the first day of the last menstrual period. Clinicians also use the same combination after an early miscarriage to help the body pass the pregnancy tissue. That use is not in the US label, but the Society of Family Planning recommends it: in a large trial, adding mifepristone raised the share of people who passed the tissue after one misoprostol dose from about two in three to about five in six. The second is Korlym (and a generic version), a daily tablet for adults with Cushing's syndrome, a condition in which the body makes too much cortisol. It is approved to control high blood sugar caused by that excess cortisol in people with type 2 diabetes or glucose intolerance whose surgery did not cure the condition or who cannot have surgery. It is not a treatment for ordinary type 2 diabetes.
Progesterone is the hormone that keeps the lining of the uterus in place and supports an early pregnancy. Mifepristone attaches to the body's progesterone receptors and blocks them, so the lining of the uterus and the cervix change and can no longer support the pregnancy. It also makes the uterus more responsive to misoprostol, which a day or two later causes the contractions that empty the uterus. At the higher daily doses used for Cushing's syndrome, mifepristone also blocks the receptor that cortisol acts on. Cortisol levels in the blood stay high, or even rise, but the hormone has less effect on the body's tissues, which improves blood sugar control and some other effects of the condition. Because the drug blocks progesterone at these doses too, it still ends a pregnancy.
For ending a pregnancy, the usual regimen is one 200 mg mifepristone tablet swallowed on the first day, then 24 to 48 hours later four misoprostol tablets held in the cheeks (two on each side) for 30 minutes before swallowing what is left. The timing matters: misoprostol taken too early or too late may work less well. Most people pass the pregnancy within 2 to 24 hours of taking misoprostol, and it can start within 2 hours, so it helps to plan to be somewhere comfortable with a bathroom. Before treatment, the clinician confirms how far along the pregnancy is, sometimes with an ultrasound, and removes an intrauterine device (IUD) if one is in place. For pregnancy termination, mifepristone is available only through an FDA safety program called the Mifepristone REMS (Risk Evaluation and Mitigation Strategy). It must be prescribed by a certified clinician, the patient signs an agreement form explaining the risks, and the tablet is dispensed by the prescriber's practice or by a certified pharmacy, in person or by mail. The FDA advises against buying it online outside this program, because those products have not been checked for quality. Korlym is taken once a day with a meal, swallowed whole without splitting, crushing or chewing. It usually starts at 300 mg, and the prescriber may raise it in steps no more often than every two to four weeks, up to 1,200 mg a day, depending on response and side effects. Lower maximums apply with kidney or liver problems and with some other medicines. If treatment is paused, it restarts at the lowest dose.
With the pregnancy regimen, cramping and bleeding are the way the treatment works, not side effects. Most people bleed more heavily than during a heavy period, usually for about two days, and spotting or light bleeding lasts 9 to 16 days on average. Nausea, weakness, fever or chills, vomiting, headache, diarrhea and dizziness are also common. Serious infection and heavy bleeding are rare (fewer than 1 in 200 people in clinical studies had a serious reaction), but they can be fatal, so the warning signs matter. Soaking through two thick full-size pads an hour for two hours in a row, or fainting, needs immediate medical attention: call the contact the clinic provided right away, and go to an emergency room if no one can be reached. Call the clinic right away for a fever of 100.4°F or higher lasting more than four hours, severe abdominal pain, or abdominal pain, weakness, nausea, vomiting or diarrhea that lasts more than 24 hours after misoprostol. Serious infection can occur without a fever, which is why feeling unwell after the first day counts. With Korlym, the most common effects include nausea, tiredness, headache, low potassium, joint pain, vomiting, swelling of the legs, high blood pressure and dizziness. Its most important risk is adrenal insufficiency, meaning the body is left without enough cortisol effect. Weakness, nausea, worsening tiredness, low blood pressure or low blood sugar should be reported to the care team promptly, because blood cortisol tests cannot detect this problem while on the drug, and treatment is to stop Korlym and take steroid medicine. Korlym also thickens the lining of the uterus in many women, and any vaginal bleeding during treatment needs gynecology evaluation.
The pregnancy regimen does not end an ectopic pregnancy, one growing outside the uterus, usually in a fallopian tube. A clinician needs to rule this out first, and because the pain and bleeding of a ruptured ectopic pregnancy can resemble a normal medication abortion, the follow-up check matters. The regimen is also not used by people who have long-term steroid treatment or chronic adrenal failure (risk of sudden adrenal crisis), a bleeding disorder or take a blood thinner, the inherited blood disorder porphyria, an IUD that cannot be removed first, or a past allergy to mifepristone or misoprostol. People with Rh-negative blood may be offered an Rh immune globulin shot, as with a procedural abortion. Some medicines can lower mifepristone levels, including rifampin (an antibiotic), certain seizure medicines and the herbal supplement St. John's wort, so the clinician should know about all medicines and supplements. Korlym ends a pregnancy. A negative pregnancy test is needed before starting and after any break longer than 14 days, and pregnancy must be prevented during treatment and for one month after stopping with a non-hormonal method of birth control, unless the person has been surgically sterilized. Hormonal birth control should not be used with it. Korlym raises blood levels of many other drugs, and its effects last weeks after the last dose. It must not be combined with the cholesterol medicines simvastatin or lovastatin (risk of severe muscle damage) or with drugs that are dangerous at slightly higher levels, such as the transplant medicines cyclosporine, tacrolimus and sirolimus, and the opioid painkiller fentanyl. It blocks the effect of steroid medicines such as prednisone, so it cannot be used when steroids are lifesaving, for example after an organ transplant, and it may worsen conditions that steroids keep under control. It can affect heart rhythm (prolonging the QT interval), so other medicines with that effect need review, and certain antifungal and HIV medicines that raise its levels require lower doses.
After a medication abortion, a follow-up assessment about 7 to 14 days after taking mifepristone confirms that the pregnancy has ended, using a pregnancy hormone test, an ultrasound or a review of symptoms. Heavy bleeding alone does not prove the abortion is complete, and little or no bleeding usually means the treatment did not work. In large studies, about 96 to 97 of every 100 people had a complete abortion without needing a procedure. Success is highest earliest in pregnancy, about 98% before 7 weeks and about 93% at 9 to 10 weeks. If tissue remains, a second misoprostol dose or a suction procedure can finish it. If the pregnancy continues, which happens in under 1 in 100, a procedural abortion is recommended because birth defects have been reported after failed treatment. Another pregnancy can happen before periods return, and contraception can begin as soon as the abortion is confirmed. Korlym is a long-term treatment with regular monitoring. Changes in blood sugar, diabetes medicine needs and mood or psychiatric symptoms often show within about six weeks, while changes in appearance, acne, excess hair growth, stretch marks and weight take longer. In the study that led to approval, about 6 in 10 people with diabetes had a clear drop in blood sugar over 24 weeks, but it was a small study without a comparison group. Potassium is checked one to two weeks after starting or raising the dose and regularly afterward, because low potassium occurred in about 4 in 10 people. Doses are adjusted gradually to balance benefit against side effects.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mifepristone, what you've noticed, or ask the community a question.